Choate Investment Advisors Gilead Sciences, Inc. Transaction History

Choate Investment Advisors

$3.89 Billion
Q3 2024

A detailed history of Choate Investment Advisors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Choate Investment Advisors holds 9,369 shares of GILD stock, worth $855,858. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,369

Previous 9,496 1.34%

Holding current value

$855,858

Previous $651,000 20.58%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $8,456 - $10,666	-127 Reduced 1.34%	9,369 $785,000
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $14,903 - $17,199	-236 Reduced 2.42%	9,496 $651,000
Q1 2024 May 07, 2024	SELL	$71.58 - $87.29 $46,169 - $56,302	-645 Reduced 6.22%	9,732 $712,000
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $23,812 - $27,004	325 Added 3.23%	10,377 $840,000
Q3 2023 Oct 30, 2023	BUY	$73.94 - $80.67 $26,470 - $28,879	358 Added 3.69%	10,052 $753,000
Q2 2023 Aug 01, 2023	BUY	$76.01 - $86.7 $88,171 - $100,572	1,160 Added 13.59%	9,694 $747,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $10,127 - $11,538	-131 Reduced 1.51%	8,534 $708,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $23,993 - $34,445	385 Added 4.65%	8,665 $743,000
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $1,096 - $1,235	-19 Reduced 0.23%	8,280 $511,000
Q1 2022 Apr 29, 2022	SELL	$57.92 - $72.58 $7,819 - $9,798	-135 Reduced 1.6%	8,299 $494,000
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $1,686 - $1,914	-26 Reduced 0.31%	8,434 $612,000
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $1,624 - $1,752	-24 Reduced 0.28%	8,460 $591,000
Q2 2021 Jul 30, 2021	BUY	$63.47 - $69.35 $16,819 - $18,377	265 Added 3.22%	8,484 $584,000
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $126,994 - $159,673	-2,045 Reduced 19.92%	8,219 $519,000
Q2 2020 Jul 23, 2020	SELL	$72.34 - $84.0 $72,340 - $84,000	-1,000 Reduced 8.88%	10,264 $790,000
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $2,505 - $3,208	-40 Reduced 0.35%	11,264 $842,000
Q4 2019 Jan 28, 2020	SELL	$61.62 - $67.78 $12,940 - $14,233	-210 Reduced 1.82%	11,304 $735,000
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $72,511 - $80,040	-1,160 Reduced 9.15%	11,514 $730,000
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $2,165 - $2,428	-35 Reduced 0.28%	12,674 $856,000
Q1 2019 Apr 29, 2019	BUY	$62.53 - $70.05 $251,995 - $282,301	4,030 Added 46.43%	12,709 $826,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $17,496 - $22,831	-289 Reduced 3.22%	8,679 $543,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $16,394 - $18,151	-230 Reduced 2.5%	8,968 $692,000
Q2 2018 Jul 30, 2018	SELL	$64.88 - $75.68 $125,932 - $146,894	-1,941 Reduced 17.43%	9,198 $652,000
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $26,222 - $31,968	-360 Reduced 3.13%	11,139 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $30,238 - $35,496	425 Added 3.84%	11,499 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $798,546 - $946,494	11,074	11,074 $0

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.

Account

Choate Investment Advisors Gilead Sciences, Inc. Transaction History